Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. MDxHealth SA
  6. News
  7. Summary
    MDXH   BE0003844611

MDXHEALTH SA

(MDXH)
  Report
Real-time Euronext Bruxelles  -  11:35:15 2023-02-01 am EST
0.6380 EUR   +1.43%
12:31aMDxHealth Kicks Off $40 Million Offering of American Depositary Shares
MT
02/01MDxHealth Announces Launch of Offering of ADSsáin the United States
GL
02/01MDxHealth Announces Launch of Offering of ADSsáin the United States
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

MDxHealth SA Reports Earnings Results for the Half Year Ended June 30, 2022

08/25/2022 | 04:16pm EST

MDxHealth SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported revenue was USD 13.01 million compared to USD 10.73 million a year ago. Net loss was USD 18.1 million compared to USD 13.3 million a year ago.

Basic loss per share from continuing operations was USD 0.12 compared to USD 0.12 a year ago.


ę S&P Capital IQ 2022
Stocks mentioned in the article
ChangeLast1st jan.
MDXHEALTH SA 1.43% 0.638 Real-time Quote.6.69%
PAX DOLLAR (USDP/USD) 0.00% 1 End-of-day quote.0.03%
All news about MDXHEALTH SA
12:31aMDxHealth Kicks Off $40 Million Offering of American Depositary Shares
MT
02/01MDxHealth Announces Launch of Offering of ADSsáin the United States
GL
02/01MDxHealth Announces Launch of Offering of ADSsáin the United States
GL
01/20MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisitio..
GL
01/20MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisitio..
AQ
01/09MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance
GL
01/09MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance
AQ
01/09MDxHealth SA Provides Revenue Guidance for the Year 2022 and Reaffirms Revenue Guidance..
CI
2022Weak Investors Sentiment Weighs on American Depositary Receipts of European Equities
MT
2022Mdxhealth files U.S. Shelf Registration on Form F-3
GL
More news
Analyst Recommendations on MDXHEALTH SA
More recommendations
Financials
Sales 2022 34,6 M 37,8 M 37,8 M
Net income 2022 -37,5 M -41,0 M -41,0 M
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 104 M 113 M 113 M
Capi. / Sales 2022 3,01x
Capi. / Sales 2023 1,68x
Nbr of Employees 191
Free-Float 84,3%
Chart MDXHEALTH SA
Duration : Period :
MDxHealth SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MDXHEALTH SA
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 0,64
Average target price
Spread / Average Target -
Managers and Directors
Michael K. McGarrity Chief Executive Officer & Executive Director
Ron Kalfus Chief Financial Officer
Koen Hoffman Chairman
Miriam Reyes Executive Vice President-Operations
Joseph Sollee Chief Compliance Officer, EVP & General Counsel
Sector and Competitors
1st jan.Capi. (M$)
MDXHEALTH SA6.69%113
MODERNA, INC.-2.96%66 963
IQVIA HOLDINGS INC.13.96%43 368
LONZA GROUP AG14.99%42 273
ALNYLAM PHARMACEUTICALS, INC.-4.73%27 670
SEAGEN INC.8.19%25 813